Literature DB >> 19675263

Pharmacologic treatment of hyperthyroidism during lactation.

Miguel Marcelo Glatstein, Facundo Garcia-Bournissen, Norberto Giglio, Yaron Finkelstein, Gideon Koren.   

Abstract

QUESTION: I have a patient who has hyperthyroidism due to Graves disease. She was taking methimazole but discontinued when she found out she was pregnant. She is currently close to delivery and might require antithyroid therapy in the postpartum period. Can methimazole cross into human milk, and is breastfeeding safe for her infant? ANSWER: The exposure of infants to methimazole or propylthiouracil through breast milk is minimal and not clinically significant. Women with hyperthyroidism using methimazole or propylthiouracil should not be discouraged from breastfeeding, as the benefits of breastfeeding largely outweigh the theoretical minimal risks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675263      PMCID: PMC2726094     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  20 in total

Review 1.  Drug therapy for breast-feeding women.

Authors:  S Ito
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

2.  Pharmacokinetics of propylthiouracil in man after a single oral dose.

Authors:  D S Sitar; D B Hunninghake
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

3.  Excretion of carbimazole and propylthiouracil in breast milk.

Authors:  L C Low; J Lang; W D Alexander
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

4.  The effect of propylthiouracil and methimazole on the peripheral conversion of thyroxine to 3,5,3'-triiodothyronine in athyreotic thyroxine-maintained rats.

Authors:  J van Doorn; F Roelfsema; D van der Heide
Journal:  Acta Endocrinol (Copenh)       Date:  1983-08

5.  The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings.

Authors:  B Davidson; M Soodak; J T Neary; H V Strout; J D Kieffer; H Mover; F Maloof
Journal:  Endocrinology       Date:  1978-09       Impact factor: 4.736

6.  [Acute cholestatic hepatitis induced by propylthiouracil. Case report].

Authors:  M B Parolin; R W Lopes; J E Telles; S O Ioshii; N Hajar
Journal:  Arq Gastroenterol       Date:  2000 Apr-Jun

Review 7.  Diagnosis and treatment of Graves disease.

Authors:  Darcie D Streetman; Ujjaini Khanderia
Journal:  Ann Pharmacother       Date:  2003 Jul-Aug       Impact factor: 3.154

8.  Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole.

Authors:  Fereidoun Azizi; Majid Bahrainian; Mohammad E Khamseh; Mohsen Khoshniat
Journal:  J Pediatr Endocrinol Metab       Date:  2003-12       Impact factor: 1.634

9.  Propylthiouracil disposition in pregnant and post-partum women.

Authors:  D S Sitar; A Abu-Bakare; R J Gardiner
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

10.  Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha.

Authors:  Matjaz Humar; Hannah Dohrmann; Philipp Stein; Nikolaos Andriopoulos; Ulrich Goebel; Martin Roesslein; Rene Schmidt; Christian I Schwer; Torsten Loop; Klaus K Geiger; Heike L Pahl; Benedikt H J Pannen
Journal:  J Pharmacol Exp Ther       Date:  2007-11-30       Impact factor: 4.030

View more
  2 in total

Review 1.  Thyroid disorders in pregnancy and postpartum.

Authors:  Ashleigh Smith; Jade Eccles-Smith; Michael D'Emden; Karin Lust
Journal:  Aust Prescr       Date:  2017-12-04

Review 2.  Benign thyroid disease in pregnancy: A state of the art review.

Authors:  Efterpi Tingi; Akheel A Syed; Alexis Kyriacou; George Mastorakos; Angelos Kyriacou
Journal:  J Clin Transl Endocrinol       Date:  2016-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.